What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Inveready takes a stake in Transbiomed, the first spin-off of VHIR Inveready Seed Capital, Venture Capital led and participated by Inveready Group, has announced its investment in the company Transbiomed in its first round of funding. Inveready has taken a minority but significant in this firm, the first spin-off of Vall d'Hebron Research Institute (VHIR) in Barcel News Dr. Galiñanes participates in the special about heart attacks in '36, 5' show at BTV The head of Cardiac Surgery at the Heart Area of the University Hospital Vall d'Hebron, and head of the reparative therapy of heart group at Vall d'Hebron Institut de Recerca (VHIR), Dr. Manuel Galiñanes, explains that exercise is the key to living in health, even for people who suffer heart disease News 2nd SMD Integrated Diagnostic Workshop Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on February 9 the second Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases. The workshop second edition, led by Teresa Vallespí, hematologist of Vall d'Hebron Resea News TVE ‘Informe Semanal' highlights Vall d'Hebron as one of the pioneers in the new lines of cancer research TVE show 'Informe Semanal' covered on February 5, in the context of the ‘Day against cancer’, the new pioneering research lines that are carrying out some Spanish hospitals, including especially Vall d'Hebron. Dr. Josep Baselga, VHIO director, and Dr. Anna Vivancos, among others researchers, give th News EU communication action on VHIR’s Meta Hit project "http://www.youtube.com/user/ComedScienceFilms#p/u/8/pGpBj5T0-DY" COMED is a ‘Communication and Support Action’ within the Seventh Framework of the European Commission to communicate the results and activities of cutting-edge EU-funded health-research projects to the general public. One of them is t News A study investigates if some fat of the diet provides benefits in the treatment of Multiple Sclerosis An international study led by Dr. Xavier Montalban, responsible of the Neuroimmunology Research Group at Vall d'Hebron Research Institute (VHIR) and director of CEM-Cat, examines whether the administration of certain lipids has benefits in the treatment of Multiple Sclerosis (MS). Specifically study News Vall d'Hebron's research, finalist in the 'Vanguardia de la Ciencia' awards "http://www.vhir.org/salapremsa/noticies/noticies_detall.asp?Idioma=en&mv1=5&mv2=3&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2010&num=269" A global study of the Vall d'Hebron Universitary Hospital, led by the group of Gene Expression and Cancer at Vall d'Hebron Institute of Oncology, that identified cells w News Early treatment with antivirals reduces 13% mortality for influenza A Antiviral use in patients with influenza A can reduce up to 13% mortality if used during the first 48 hours since the first symptoms, according to results of a study coordinated by the head of the ICU department at Vall d'Hebron Hospital and reponsible of the Intensive Medicine group at Vall d'Hebro News Vall d'Hebron patents and sells a test that improves breast cancer treatment Vall d'Hebron researchers led by Dr. Joaquin Arribas have created a test to improve the treatment of breast cancer, have patented it and sold the license to the multinational pharmaceutical company GlaxoSmithKline to make it available to patients anywhere in the world. The discovery of this group of News Dr. Antolin explains on TVE the progress in the research of the intestinal flora Dr. Maria Antolin, from the research group in digestive physiology and pathophysiology of Vall d'Hebron Research Institute (VHIR), explains in the tv show 'La Mañana de la 1' of TVE, the study that points the possibility to validate treatments that can make changes in the composition of the intestin News Dr. Rello analyzes the first 100 cases of influenza A this season The head of the ICU department at Vall d'Hebron Hospital and reponsible of the Intensive Medicine group at Vall d'Hebron Research Institute (VHIR)), Dr. Jordi Rello, is examining the first hundred revenues of influenza A H1N1 in Spanish ICUs in a coordinated effort by the Spanish Society of Intensiv News VHIR leads grants for the promotion of independent clinical research Vall d'Hebron Research Institute (VHIR) is the Spanish center that has received more funding in the call of grants for the development of independent clinical research 2010 from the Health and Social Policy Ministry. VHIR submitted 18 projects, of which 13 have been accepted to be funded. The amount News Dr. Boada talks about Alzheimer at '36,5', BTV health magazine Dr. Mercè Boada, leader of Alzheimer’s group at Vall d'Hebron Research Institute (VHIR), participates in a program dedicated to Alzheimer at '36.5' , BTV show presented by Dr. Eduard Estivil. The health magazine, with the collaboration of researchers from Vall d'Hebron, Hospital Clínic, Hospital del News Dr. Orriols participates in 'Uncomfortable patients' on tv show '30 Minuts' Dr. Ramon Orriols, member of the Pneumology group at Vall d'Hebron Research Institute (VHIR) participates in the article 'Uncomfortable patients' that deals with the Multiple Chemical Sensitivity in the tv whow '30 minuts’ of TV3. Multiple chemical sensitivity is a little-known disease in which ther News VALOR 2010 will support the kit for the early diagnosis of prostate cancer in urine The project ‘Validation and commercialization of a kit for early diagnosis of prostate cancer in urine' that develops the Biomedical Research and translational and pediatric Oncology Unit of Vall d' Hebron Research Institute (VHIR), has been awarded a grant from the call VALOR 2010. This AGAUR compe News The genetic analysis is key in pediatric research Research and genetic analysis research are key to new approaches for pediatric use, as concluded in a discussion on child health that took place during the Fourth Conference of Updating Biomedical Researc.. At the conference, organized by the Ophthalmology Research Unit Santiago Grisolia, which belo News VHIR chats with Diario Médico readers Dr. Joan X. Comella participated on 13 January in a chat with the readers of the journal Diario Médico. The director of Vall d'Hebron Research Institute (VHIR) answered questions about translational medical research: from the hospital bed to the lab and from the lab back to the hospital bed. "http: News VHIR works with an innovative project that extends the application of pulse oximetry The team of Jordi Rello, head of the ICU department at Vall d'Hebron Hospital and reponsible of the Intensive Medicine group at Vall d'Hebron Research Institute (VHIR), together with Juan Carlos Ruiz, member of the of Shock, Organ Dysfunction and Resuscitation group (SODIR) at VHIR and attending doc News VHIR begins to develop the 2011-2015 Strategic Plan On 20 and 22 December took place at Hotel Alimara of Barcelona the first meetings aimed to develope the 2011-2015 Strategic Plan of Vall d'Hebron Research Institute (VHIR). During the first day worked groups formed by the direction of the hospital and the Research Institute, members of the Internal News Dr. Reventós explains the latest developments in his research to patients and families The head of the Biomedical Research and Translational and Pediatric Oncology Unit at Vall d'Hebron, Institut de Recerca (VHIR), Dr. Jaume Reventós, participated in a session aimed at prostate cancer patients and their families, where he explained the latest developments in the investigation of his g Pagination First page « Previous page ‹ … Page 160 Page 161 Current page 162 Page 163 Page 164 … Next page › Last page »
